There are many things that are far from obvious for you. No such interview about loading many tumor-associated antigens on DCs is bad. No one except NWBO and UCLA team can load DCs with many tumor-associated antigens. How could she/he talk about the aftermath of loading too many tumor-associated antigens?
Market Data 
Markets 
AI
